Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chemotherapy-induced cognitive impairments: A systematic review of the animal literature
A. Matsos, Ian N. Johnston
Neuroscience & Biobehavioral Reviews (2019) Vol. 102, pp. 382-399
Closed Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Mechanisms of Chemotherapy-Induced Neurotoxicity
Halina Waś, Agata Borkowska, Ana Bagüés, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 129
Long-Term Cognitive Dysfunction in Cancer Survivors
Zuzana Országhová, Michal Mego, Michal Chovanec
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 102
Cognitive adverse effects of chemotherapy and immunotherapy: are interventions within reach?
Sanne B. Schagen, Andrey S. Tsvetkov, Annette Compter, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 3, pp. 173-185
Closed Access | Times Cited: 65
Attention and memory after COVID-19 as measured by neuropsychological tests: Systematic review and meta-analysis
Boris B. Velichkovsky, A.Y. Razvaliaeva, Alena A. Khlebnikova, et al.
Acta Psychologica (2023) Vol. 233, pp. 103838-103838
Open Access | Times Cited: 24
Cancer related cognitive impairment: a downside of cancer treatment
Kimberly Demos-Davies, Jessica Lawrence, Davis Seelig
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 10
Complications and comorbidities associated with antineoplastic chemotherapy: Rethinking drug design and delivery for anticancer therapy
Xiaoman Mao, Shuang Wu, Dandan Huang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2901-2926
Open Access | Times Cited: 8
Attenuation of neuroinflammation reverses Adriamycin-induced cognitive impairments
Barrett D. Allen, Lauren A. Apodaca, Amber R. Syage, et al.
Acta Neuropathologica Communications (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 56
“Amyloid‐beta accumulation cycle” as a prevention and/or therapy target for Alzheimer's disease
Chinthalapally V. Rao, Adam S. Asch, Daniel J.J. Carr, et al.
Aging Cell (2020) Vol. 19, Iss. 3
Open Access | Times Cited: 55
Chemotherapy-Induced Cognitive Impairment and Hippocampal Neurogenesis: A Review of Physiological Mechanisms and Interventions
Melanie J. Sekeres, Meenakshie Bradley-Garcia, Alonso Martínez-Canabal, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12697-12697
Open Access | Times Cited: 50
Programmed ageing: decline of stem cell renewal, immunosenescence, and Alzheimer's disease
Richard Lathe, David St Clair
Biological reviews/Biological reviews of the Cambridge Philosophical Society (2023) Vol. 98, Iss. 4, pp. 1424-1458
Open Access | Times Cited: 18
Animal models of chemotherapy-induced cognitive decline in preclinical drug development
Jeena John, Manas Kinra, Jayesh Mudgal, et al.
Psychopharmacology (2021) Vol. 238, Iss. 11, pp. 3025-3053
Open Access | Times Cited: 37
Neuroprotective effect of Mulmina Mango against chemotherapy-induced cognitive decline in mouse model of mammary carcinoma
Jeena John, Manas Kinra, Niraja Ranadive, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 24
DNA Damage and Repair in Migraine: Oxidative Stress and Beyond
Michał Fila, Aleksandra Jabłkowska, Elżbieta Pawłowska, et al.
The Neuroscientist (2022) Vol. 29, Iss. 3, pp. 277-286
Closed Access | Times Cited: 22
Antineoplastics for treating Alzheimer's disease and dementia: Evidence from preclinical and observational studies
Viswanath Das, John H. Miller, Alladi Charanraj Goud, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 5, pp. 2078-2111
Open Access | Times Cited: 5
The Use of Heptamethine Cyanine Dyes as Drug-Conjugate Systems in the Treatment of Primary and Metastatic Brain Tumors
Elizabeth Cooper, Peter J. Choi, William A. Denny, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 28
Early life environmental enrichment yields resilience to selected behavioural and brain responses to 5-fluorouracil in mice
Keng-Ting Sun, Jimmy W.Y. Lam, Mandy Ng, et al.
Brain Behavior and Immunity (2025)
Open Access
Meta-analyses of executive function deficits in chemotherapy-treated rodent models
Weiye Chen, Ian N. Johnston
Neuroscience & Biobehavioral Reviews (2025), pp. 106131-106131
Open Access
Structural Neuroimaging Findings Related to Adult Non-CNS Cancer and Treatment: Review, Integration, and Implications for Treatment of Cognitive Dysfunction
Brenna C. McDonald
Neurotherapeutics (2021) Vol. 18, Iss. 2, pp. 792-810
Open Access | Times Cited: 26
Cancer-related cognitive impairment is associated with perturbations in inflammatory pathways
Kate Oppegaard, Carolyn Harris, Joosun Shin, et al.
Cytokine (2021) Vol. 148, pp. 155653-155653
Open Access | Times Cited: 24
A facile and universal method to achieve liposomal remote loading of non-ionizable drugs with outstanding safety profiles and therapeutic effect
Shuang Zhou, Jinbo Li, Jiang Yu, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 11, Iss. 1, pp. 258-270
Open Access | Times Cited: 24
Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events
Ana Dias-Carvalho, Mariana Ferreira, Rita Ferreira, et al.
Archives of Toxicology (2021) Vol. 96, Iss. 1, pp. 11-78
Closed Access | Times Cited: 21
Methodological shortcomings of preclinical research on chemotherapy-induced cognitive impairment
Victoria Aurora Ossorio Salazar, Rudi D’Hooge
Neuroscience & Biobehavioral Reviews (2023) Vol. 150, pp. 105198-105198
Closed Access | Times Cited: 8
Neuroimmune reactivity marker expression in rodent models of chemotherapy-induced cognitive impairment: A systematic scoping review
Rebecca P. George, Ines Semendric, Mark R. Hutchinson, et al.
Brain Behavior and Immunity (2021) Vol. 94, pp. 392-409
Closed Access | Times Cited: 20
Interventions promoting cognitive function in patients experiencing cancer related cognitive impairment: A systematic review
Laura Oldacres, Josephine Hegarty, Patricia O’Regan, et al.
Psycho-Oncology (2022) Vol. 32, Iss. 2, pp. 214-228
Open Access | Times Cited: 13
Cancer treatment induces neuroinflammation and behavioral deficits in mice
Kimberly Demos-Davies, Jessica Lawrence, Allison Rogich, et al.
Frontiers in Behavioral Neuroscience (2023) Vol. 16
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top